Amalgamated Bank Has $1.65 Million Stake in DENTSPLY SIRONA Inc. (XRAY)

Amalgamated Bank lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 57.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,452 shares of the medical instruments supplier’s stock after purchasing an additional 9,296 shares during the quarter. Amalgamated Bank’s holdings in DENTSPLY SIRONA were worth $1,650,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of XRAY. Commonwealth Bank of Australia grew its stake in shares of DENTSPLY SIRONA by 19.0% during the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the period. Dupont Capital Management Corp acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $116,000. Korea Investment CORP grew its stake in shares of DENTSPLY SIRONA by 139.9% during the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock worth $139,000 after purchasing an additional 1,251 shares during the period. Sphera Funds Management LTD. acquired a new stake in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $162,000. Finally, Penserra Capital Management LLC grew its stake in shares of DENTSPLY SIRONA by 9.5% during the 1st quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock worth $172,000 after purchasing an additional 240 shares during the period. 93.87% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 58.65 on Thursday. The stock’s market cap is $13.46 billion. The stock’s 50 day moving average price is $56.98 and its 200-day moving average price is $61.67. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. During the same quarter in the prior year, the company posted $0.76 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis. Equities research analysts predict that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be issued a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

TRADEMARK VIOLATION WARNING: “Amalgamated Bank Has $1.65 Million Stake in DENTSPLY SIRONA Inc. (XRAY)” was posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this piece can be accessed at https://www.themarketsdaily.com/2017/09/21/amalgamated-bank-has-1-65-million-stake-in-dentsply-sirona-inc-xray.html.

A number of brokerages have recently commented on XRAY. HC Wainwright reaffirmed a “buy” rating and set a $68.00 price objective (down previously from $74.00) on shares of DENTSPLY SIRONA in a research note on Monday, August 14th. TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research note on Wednesday, August 9th. Morgan Stanley raised their price objective on shares of DENTSPLY SIRONA from $66.00 to $67.00 and gave the stock an “overweight” rating in a research note on Thursday, August 10th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price objective on the stock in a research note on Thursday, July 13th. Finally, BidaskClub cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, June 10th. Three research analysts have rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $65.73.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply